Fluoxetine for overweight and obesity

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2008, Pages

  Aponte, Juan Camilo ^a   Ballesteros, Bibiana ^b   Deantonio, Rodrigo ^c  

^a Fundacion Universitaria de Ciencias de la Salud   (Colombia)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

^c INSTITUTO NACIONAL DE SALUD   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PLACEBO;

CAUSE OF DEATH; CLINICAL PROTOCOL; CLINICAL TRIAL; COCHRANE LIBRARY; DRUG COST; DRUG EFFECT; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; EMBASE; HUMAN; INFORMATION RETRIEVAL; MEDICAL LITERATURE; MEDLINE; MENTAL HEALTH; OBESITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION; WELLBEING;

EID: 55049094893     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007305     Document Type: Review

References (38)

1. Arterburn 2001 David Arterburn, Polly Hitchcock Noel. Obesity. Clinical Evidence. Vol. 322, BMJ, 2001:1406-1409.
2. Bhandari 2005 Kalpana Bhandari, A Shipra Srivastava, et al.Substituted propanolamines and alkylamines derived from fluoxetine as potent appetite suppressants. Bioorganic & Medicinal Chemistry 2005;13:17391747.
3. Canoy 2007 D. Canoy, I. Buchan. Challenges in obesity epidemiology. Obesity reviews. The International Association for the Study of Obesity 2007;8(Suppl. 1):111.
4. Cohen 1960 Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960;20:37-46.
5. Cynthia 2006 Cynthia L. Ogden, PhD, Margaret D. Carroll, MSPH, Lester R. Curtin, PhD, Margaret A. McDowell, MPH, RD, Carolyn J. Tabak, MD, MPH, Katherine M. Flegal, PhD. Prevalence of Overweight and Obesity in the United States, 1999-2004. JAMA 2006, (295):1549-1555. 1549-1555..
6. Douketis 1999 Douketis JD, Feightner JW, Attia J. Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity [Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity]. Can Med Assoc J 1999;160(4):513-525.
7. Egger 2001 Egger M, Smith GD, Altman DG. Systematic reviews in health care: meta-analysis in context. 2nd Edition. London: BMJ Books, 2001. [MEDLINE: 16]
8. Flegal 2005 Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity.. JAMA 2005, (293):18611867.
9. Goldstein 1994 Goldstein DJ, Rampey Jr AH, Enas GG. Fluoxetine: a randomized clinical trial in the treatment of obesity [Fluoxetine: a randomized clinical trial in the treatment of obesity]. Int J Obes 1994;18:129-135.
10. Haddock 2001 Haddock CK, Poston WSC, Dill PL, Foreyt JP, Ericsson M. Pharmacotherapy for obesity: a quantitative analysisof four decades of published randomized clinical trials. International Journal of Obesity 2002, (26):262273.
11. Heymesfield 1999 Heymesfield Sb, Greenberg AS, Fujioka K, et al. Recombinant leptin for weigth loss in obese and lean adults. JAMA 1999;16:1568-5.
12. Higgins 2002 Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in medicine 2002;21:1539-58.
13. Higgins 2003 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557- 60.
14. Higgins 2008 Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochranehandbook. org..
15. James 2001 JAMES M. LYZNICKI, M.S, M.P.H, DONALD C. YOUNG, M.D, et al. Obesity: Assessment and Management in Primary Care.. Am Fam Physician 2001;63:2185-96.
16. Jason 2007 Jason C.G. Halford, Joanne A. Harrold, Emma J. Boyland, et al.Serotonergic Drugs Effects on Appetite Expression and Use for the Treatment of Obesity. Drugs 2007;67(1):27-55.
17. Lau 2006 Lau J, Ioannidis JPA, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. BMJ 2006;333:597-600.
18. Letón 2001 Letón E, Pedromingo A. Introduction to data analysis in meta-analyisis. Introducción al Análisis de Datos en Meta-análisis. Madrid: Ediciones Diaz de Santos, 2001. [MEDLINE: 14]
19. Loanndines 2005 Lisa L. Loanndines-Demos Joseph Proietto, Jhonn J. McNeill. Pharmacoterapy for Obesity. Drugs 2005;65(10):1391-1418.
20. Moher 1999 Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354(9193):1896-900.
21. Mulrow 1998 Mulrow CD, Williams Jr JW, Trivedi M. Treatment of depression newer pharmacotherapies [Treatment of depression newer pharmacotherapies]. Psychopharmacol Bull 1998;34:409-795.
22. National Task Force 1996 National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity [Long-term pharmacotherapy in the management of obesity]. JAMA 1996;276(23):1907-1915.
23. NHCS 1994 National Center for Health Statistics. Third National Health And nutrition examination survey 1988 - 1994 Third National Health And nutrition examination survey 1988 - 1994.
24. NHS 1997 Glenny AM, O'Meara S, Melville A, Sheldon TA, Wilson C. NHS Centre for Reviews and Dissemination, University of York, Heslington. The treatment and prevention of obesity: a systematic review of the literature.. International Journal of Obesity 1997;21:715-737.
25. NIH NHLB 1998 National Institutes of Health, National Heart, Lung, and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. Obes Res 1998;6(suppl 2):51S-209S.
26. Padwal 2003 Padwal R, Li SK, Lau DCW. Long-term pharmacotherapy for obesity and overweight. The Cochrane Library October 2003, (4).
27. Palamara 2006 Kerri L. Palamara, MD, * Harriette R. Mogul, MD, MPH, † Stephen J. Obesity New Perspectives and Pharmacotherapies. Cardiology in Review September/October 2006;14(5).
28. Phyllis 2005 Phyllis W. Speiser, Mary C. J. Rudolf, Henry Anhalt, Cecilia Camacho-Hubner, Francesco Chiarelli, Alon Eliakim, Michael Freemark, Annette Gruters. Et al. CONSENSUS STATEMENT: Childhood Obesity.. J Clin Endocrinol Metab 2005;90:18711887.
29. Rosamond 2007 Wayne Rosamond, PhD, Katherine Flegal, PhD*, Gary Friday, MD, MPH, Karen Furie, MD, Alan Go, MD, Kurt Greenlund, PhD, et al.Heart Disease and Stroke Statistics2007 Update. American Hearth Association Statistics Committee and Stroke Statistics Subcommittee Circulation 2007, (115):e69-e171.
30. Sterne 2001 Sterne JAC, Egger M, Davey Smith G. Investigating and dealing with publication and other biases. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic Reviews in Health Care; Meta-analysis in Context. London: BMJ Publishing Group, 2001:189-208.
31. Sutton 2000 Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. Methods for meta-analysis in medical research. Chichester, UK: John Wiley & Sons, Ltd., 2000. [MEDLINE: 15]
32. Task Force 1996 U.S. Preventive Services Task Force. Screening for obesity. Guide to clinical preventive services. 2d ed. Baltimore, Md: Williams & Wilkins, 1996:219-29.
33. U.S. Health 1996 U.S. Department of Health and Human Services. Physical activity and health: a report of the surgeon general. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 1996.
34. WHO 1998 World Health Organization. Obesity: preventing and managing the global epidemic.. WHO/NUT/98.1. Geneva, Switzerland: World Health Organization, 1998.
35. WHO 2006 World Health Organization. Obesity and Overweight [Obesity and Overweight]. http://www.who.int/mediacentre/factsheets/fs311/en/ print.html September 2006;Fact Sheet No. 311.
36. Yanosvski 1999 Yanosvski JA, Yanosvski SZ. Recent Advances in basic obesity research. JAMA 1999;282:1504-1506.
37. Yanovski 2002 Susan Z. Yanovski M.D, Jack A. Yanovski. M.D. PH.D. Obesity. N Engl J Med 2002;346(8).
38. Zhaoping 2005 Zhaoping Li, MD, PhD, Margaret Maglione, MPP, Wenli Tu, MS, Walter Mojica, et al.Meta-Analysis: Pharmacologic Treatment of Obesity.. Ann Intern Med 2005;142:532-546.